Position in REGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$35,899,068
-$9,055,445 QoQ
Shares Held
57,573
-1.0% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
1.60%
of 13F equity value
Holder Rank
#150
of 1,322 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAMBIAR INVESTORS LLC holds $37,710,157 across 2 Biotechnology names. REGN ranks #1 (95.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
57,573 | $35,899,068 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
23,139 | $1,811,089 |
All Filings in REGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,899,068 | 57,573 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $44,954,513 | 58,183 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $46,438,014 | 60,163 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $33,226,783 | 59,094 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $32,796,750 | 62,470 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $31,908,111 | 50,310 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||